SCHEMBL9607232

SCHEMBL9607232

COc1ccc2c(Cl)cc(-c3cnn(Cc4ccc(OC(F)(F)F)cc4)c3)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
KLKB1 P03952 1/20 0.39
CYP3A4 P08684 1/20 0.39
KCNH2 Q12809 2/20 0.38
MAPT P10636 2/20 0.38
GRM2 Q14416 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.37
TACR3 P29371 2/20 0.37
PGK1 P00558 1/20 0.37
CHRM5 P08912 1/20 0.37
SMYD3 Q9H7B4 1/20 0.37
NTRK1 P04629 1/20 0.36
CSF1R P07333 1/20 0.36
NTRK2 Q16620 1/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536085 0.87 ACP1 (0.47) ABL1BCRKLKB1KCNH2MAPT
SCHEMBL8534140 0.74 ALDH1A1 (0.45) KLKB1MAPTKDM4EALDH1A1HPGD
SCHEMBL18097397 0.73 PDE2A (0.47) ABL1BCRKLKB1KCNH2CHRM5
SCHEMBL8538579 0.73 MAT2A (0.61) ABL1BCRKLKB1KCNH2CHRM5
SCHEMBL9607518 0.72 LMNA (0.47) MAPTKDM4EALDH1A1LMNAPGK1
SCHEMBL5480798 0.71 PDE10A (0.48) KCNH2NTRK1CSF1RNTRK2
SCHEMBL24930970 0.71 CSNK2A1 (0.41) KLKB1KCNH2MAPTGRM2KDM4E
SCHEMBL30239845 0.71 CSNK2A1 (0.41) KLKB1KCNH2MAPTGRM2KDM4E
SCHEMBL6534170 0.71 KDM4E (0.58) CYP3A4MAPTKDM4EALDH1A1HPGD
SCHEMBL9607226 0.70 TRPM8 (0.44) ABL1BCRKLKB1KCNH2PGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069856-A1 ANTIMALARIAL COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2012-05-31 WO disclosed